ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)

NCT02935855 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Diabetes

Interventions

DRUG: Dabigatran
DRUG: Apixaban
DRUG: Rivaroxaban
DRUG: Edoxaban
DRUG: Warfarin
DRUG: Acenocumarole

Sponsor

University of Pavia